USD 1.48
(-2.63%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 | 1.19 Million USD | -22.99% |
2023 | 1.54 Million USD | 736.08% |
2022 | 184.81 Thousand USD | -93.43% |
2021 | 2.81 Million USD | 937.86% |
2020 | 270.95 Thousand USD | 0.0% |
2019 | - USD | -100.0% |
2018 | 516.00 USD | -97.57% |
2017 | 21.25 Thousand USD | -83.79% |
2016 | 131.09 Thousand USD | 8.85% |
2015 | 120.42 Thousand USD | 20.11% |
2014 | 100.26 Thousand USD | 10.13% |
2013 | 91.04 Thousand USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 FY | 1.19 Million USD | -22.99% |
2024 Q3 | 1.27 Million USD | -6.03% |
2024 Q1 | 1.43 Million USD | -6.87% |
2024 Q2 | 1.35 Million USD | -5.56% |
2024 Q4 | 1.19 Million USD | -6.81% |
2023 FY | 1.54 Million USD | 736.08% |
2023 Q2 | 114.36 Thousand USD | -23.79% |
2023 Q1 | 150.07 Thousand USD | -18.8% |
2023 Q4 | 1.54 Million USD | 1889.38% |
2023 Q3 | 77.67 Thousand USD | -32.09% |
2022 Q4 | 184.81 Thousand USD | -97.43% |
2022 FY | 184.81 Thousand USD | -93.43% |
2022 Q3 | 7.2 Million USD | 41.11% |
2022 Q2 | 5.1 Million USD | 9.78% |
2022 Q1 | 4.64 Million USD | 65.33% |
2021 Q2 | 839.24 Thousand USD | -6.85% |
2021 FY | 2.81 Million USD | 937.86% |
2021 Q4 | 2.81 Million USD | 262.0% |
2021 Q3 | 776.82 Thousand USD | -7.44% |
2021 Q1 | 900.93 Thousand USD | 232.51% |
2020 Q4 | 270.95 Thousand USD | 0.0% |
2020 FY | 270.95 Thousand USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 FY | - USD | -100.0% |
2019 Q4 | - USD | 0.0% |
2019 Q1 | - USD | -100.0% |
2018 Q2 | - USD | 0.0% |
2018 FY | 516.00 USD | -97.57% |
2018 Q1 | - USD | -100.0% |
2018 Q3 | - USD | 0.0% |
2018 Q4 | 516.00 USD | 0.0% |
2017 FY | 21.25 Thousand USD | -83.79% |
2017 Q4 | 21.25 Thousand USD | -85.03% |
2017 Q3 | 141.98 Thousand USD | 1.57% |
2017 Q2 | 139.79 Thousand USD | 6.64% |
2017 Q1 | 131.09 Thousand USD | 1.36% |
2016 FY | 131.09 Thousand USD | 8.85% |
2016 Q4 | 129.33 Thousand USD | 1.68% |
2016 Q2 | 121.2 Thousand USD | 0.64% |
2016 Q3 | 127.19 Thousand USD | 4.94% |
2016 Q1 | 120.42 Thousand USD | 1.47% |
2015 Q2 | 102.23 Thousand USD | 1.97% |
2015 FY | 120.42 Thousand USD | 20.11% |
2015 Q1 | 100.26 Thousand USD | 0.19% |
2015 Q4 | 118.68 Thousand USD | 1.93% |
2015 Q3 | 116.44 Thousand USD | 13.9% |
2014 Q4 | 100.07 Thousand USD | 2.2% |
2014 Q1 | 91.04 Thousand USD | 0.0% |
2014 Q2 | 95.02 Thousand USD | 4.37% |
2014 FY | 100.26 Thousand USD | 10.13% |
2014 Q3 | 97.92 Thousand USD | 3.05% |
2013 Q4 | - USD | 0.0% |
2013 FY | 91.04 Thousand USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2004 FY | - USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Alphatec Holdings, Inc. | 541.67 Million USD | 99.78% |
Nemaura Medical Inc. | 20.03 Million USD | 94.059% |
NeuroPace, Inc. | 72.39 Million USD | 98.356% |
LENSAR, Inc. | 2.3 Million USD | 48.463% |
Rapid Micro Biosystems, Inc. | 7.34 Million USD | 83.801% |
TriSalus Life Sciences, Inc. | 1.59 Million USD | 25.392% |
Apyx Medical Corporation | 38.5 Million USD | 96.909% |
Cutera, Inc. | 431.91 Million USD | 99.724% |
STRATA Skin Sciences, Inc. | 15.63 Million USD | 92.388% |
BioSig Technologies, Inc. | 452 Thousand USD | -163.274% |
Accelerate Diagnostics, Inc. | 39.22 Million USD | 96.966% |
Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 99.929% |
Axonics, Inc. | 27.61 Million USD | 95.691% |
IRIDEX Corporation | 2.74 Million USD | 56.664% |
PROCEPT BioRobotics Corporation | 79.2 Million USD | 98.498% |
TELA Bio, Inc. | 42.78 Million USD | 97.218% |
Tivic Health Systems, Inc. | 369 Thousand USD | -222.493% |
RxSight, Inc. | 3.01 Million USD | 60.491% |
Align Technology, Inc. | 96.96 Million USD | 98.773% |
INVO Bioscience, Inc. | 8.68 Million USD | 86.296% |
electroCore, Inc. | 626 Thousand USD | -90.096% |
Telesis Bio, Inc. | 34.38 Million USD | 96.539% |
Viemed Healthcare, Inc. | 10.27 Million USD | 88.414% |
Quipt Home Medical Corp. | 98.94 Million USD | 98.797% |
Anika Therapeutics, Inc. | 29.03 Million USD | 95.902% |
Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 49.319% |
Lucid Diagnostics Inc. | 15.25 Million USD | 92.199% |
Dynatronics Corporation | 6.68 Million USD | 82.207% |
ReShape Lifesciences Inc. | 262 Thousand USD | -354.198% |
Talis Biomedical Corporation | 19.66 Million USD | 93.95% |
PetVivo Holdings, Inc. | 1.36 Million USD | 12.823% |
InMode Ltd. | 9.01 Million USD | 86.803% |
Envoy Medical, Inc. | 404 Thousand USD | -194.554% |
Bruker Corporation | 1.37 Billion USD | 99.914% |
Helius Medical Technologies, Inc. | 57 Thousand USD | -1987.719% |
DexCom, Inc. | 2.59 Billion USD | 99.954% |
Nexalin Technology, Inc. | 4463.00 USD | -26563.679% |
PAVmed Inc | 48.72 Million USD | 97.558% |
Viveve Medical, Inc. | 5.34 Million USD | 77.753% |
Cerus Corporation | 95.99 Million USD | 98.76% |
Movano Inc. | 252 Thousand USD | -372.222% |
Cytek Biosciences, Inc. | 33.17 Million USD | 96.413% |
Nexalin Technology, Inc. | 4463.00 USD | -26563.679% |
IceCure Medical Ltd | 599 Thousand USD | -98.664% |
Tandem Diabetes Care, Inc. | 415.66 Million USD | 99.714% |
enVVeno Medical Corporation | 1.4 Million USD | 15.121% |
908 Devices Inc. | 5.94 Million USD | 79.983% |
ClearPoint Neuro, Inc. | 13.94 Million USD | 91.464% |
Orthofix Medical Inc. | 134.19 Million USD | 99.113% |
Surmodics, Inc. | 29.4 Million USD | 95.953% |
Nuwellis, Inc. | 981 Thousand USD | -21.305% |
Outset Medical, Inc. | 136.18 Million USD | 99.126% |
Venus Concept Inc. | 79.69 Million USD | 98.507% |
iRhythm Technologies, Inc. | 129.82 Million USD | 99.083% |
Treace Medical Concepts, Inc. | 70.3 Million USD | 98.307% |
Nano-X Imaging Ltd. | 8.39 Million USD | 85.827% |
Aethlon Medical, Inc. | 940.31 Thousand USD | -26.553% |
Inogen, Inc. | 21.92 Million USD | 94.572% |
IRadimed Corporation | 2.04 Million USD | 41.754% |
MaxCyte, Inc. | 18.74 Million USD | 93.651% |
Pulmonx Corporation | 41.42 Million USD | 97.127% |
PAVmed Inc. | 48.72 Million USD | 97.558% |
iCAD, Inc. | 461 Thousand USD | -158.134% |
OrthoPediatrics Corp. | 23.76 Million USD | 94.992% |
DIH Holding US, Inc. Warrants | 1.99 Million USD | 40.396% |
Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -141.874% |
NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -545.336% |
SI-BONE, Inc. | 38.99 Million USD | 96.948% |
Semler Scientific, Inc. | 70 Thousand USD | -1600.0% |
Beyond Air, Inc. | 17.83 Million USD | 93.328% |
FONAR Corporation | 41.67 Million USD | 97.145% |
AxoGen, Inc. | 69.29 Million USD | 98.283% |
Biotricity, Inc. | 23.87 Million USD | 95.016% |
Cytosorbents Corporation | 18.31 Million USD | 93.502% |
ZimVie Inc. | 521.92 Million USD | 99.772% |
Tactile Systems Technology, Inc. | 50.37 Million USD | 97.638% |
Inari Medical, Inc. | 32.04 Million USD | 96.287% |
UFP Technologies, Inc. | 46.03 Million USD | 97.415% |
DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | 40.396% |
QT Imaging Holdings, Inc. | 3.07 Million USD | 61.251% |
Sight Sciences, Inc. | 35.41 Million USD | 96.64% |
Insulet Corporation | 1.44 Billion USD | 99.918% |
Profound Medical Corp. | 7.9 Million USD | 84.937% |
Bioventus Inc. | 409.47 Million USD | 99.709% |
InspireMD, Inc. | 1.59 Million USD | 25.392% |
BrainsWay Ltd. | 471 Thousand USD | -152.654% |
BIOLASE, Inc. | 17.91 Million USD | 93.356% |
Heart Test Laboratories, Inc. | 1.03 Million USD | -14.827% |
Tenon Medical, Inc. | 1.17 Million USD | -1.449% |
Autonomix Medical, Inc. Common Stock | 1 Million USD | -18.762% |
CVRx, Inc. | 30.61 Million USD | 96.113% |
AdaptHealth Corp. | 2.29 Billion USD | 99.948% |
Sintx Technologies, Inc. | 4.24 Million USD | 71.967% |
Acutus Medical, Inc. | 38.47 Million USD | 96.907% |
Vivos Therapeutics, Inc. | 1.99 Million USD | 40.351% |
NanoVibronix, Inc. | 5000.00 USD | -23700.0% |
Quanterix Corporation | 41.46 Million USD | 97.13% |
LivaNova PLC | 640.4 Million USD | 99.814% |
Co-Diagnostics, Inc. | 2.99 Million USD | 60.208% |
Varex Imaging Corporation | 469.5 Million USD | 99.747% |
Vivani Medical, Inc. | 20.69 Million USD | 94.25% |
Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | 49.319% |
Sensus Healthcare, Inc. | 783 Thousand USD | -51.98% |
Pacific Biosciences of California, Inc. | 933.93 Million USD | 99.873% |
TransMedics Group, Inc. | 515.94 Million USD | 99.769% |
ReWalk Robotics Ltd. | 1.9 Million USD | 37.467% |
NeuroMetrix, Inc. | 240.87 Thousand USD | -394.03% |
Spectral AI, Inc. | 1.28 Million USD | 7.68% |
Hyperfine, Inc. | 185 Thousand USD | -543.243% |
Establishment Labs Holdings Inc. | 192.22 Million USD | 99.381% |
Biomerica, Inc. | 785 Thousand USD | -51.592% |
Bone Biologics Corporation | - USD | -Infinity% |
AVITA Medical, Inc. | 449.48 Thousand USD | -164.749% |
Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -221.53% |
Silk Road Medical, Inc | 84.63 Million USD | 98.594% |